Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Balances at Dec. 31, 2020	$ 1,964	$ 102,651,304	$ (98,234,151)	$ 160,642	$ 4,579,759
Balances (in Shares) at Dec. 31, 2020	19,642,519
Stock-based compensation		2,261,126			2,261,126
Settlement of accrued expense with stock options		349,376			349,376
Convertible note converted to common stock	$ 117	6,232,223			6,232,340
Convertible note converted to common stock (in Shares)	1,171,296
Cashless stock option exercise	$ 30	(30)
Cashless stock option exercise (in Shares)	286,453
Cashless warrant exercise	$ 26	(26)
Cashless warrant exercise (in Shares)	262,759
Net loss			(5,547,609)		(5,547,609)
Foreign currency translation				42,025	42,025
Balances at Jun. 30, 2021	$ 2,137	111,493,973	(103,781,760)	202,667	7,917,017
Balances (in Shares) at Jun. 30, 2021	21,363,027
Balances at Mar. 31, 2021	$ 2,012	103,401,916	(100,724,150)	200,998	2,880,776
Balances (in Shares) at Mar. 31, 2021	20,116,348
Stock-based compensation		1,634,546			1,634,546
Settlement of accrued expense with stock options		349,376			349,376
Convertible note converted to common stock	$ 114	6,108,146			6,108,260
Convertible note converted to common stock (in Shares)	1,138,346
Cashless stock option exercise	$ 11	(11)
Cashless stock option exercise (in Shares)	108,333
Net loss			(3,057,610)		(3,057,610)
Foreign currency translation				1,669	1,669
Balances at Jun. 30, 2021	$ 2,137	111,493,973	(103,781,760)	202,667	7,917,017
Balances (in Shares) at Jun. 30, 2021	21,363,027
Balances at Dec. 31, 2021	$ 2,329	126,581,702	(115,899,939)	211,486	10,895,578
Balances (in Shares) at Dec. 31, 2021	23,294,024
Stock-based compensation		4,499,107			4,499,107
Sale of common stock for cash, net of offering costs	$ 106	3,146,834			3,146,940
Sale of common stock for cash, net of offering costs (in Shares)	1,063,514
Common stock issued with convertible debt	$ 3	91,754			91,757
Common stock issued with convertible debt (in Shares)	28,496
Common stock issued for working capital facility	$ 10	302,990			303,000
Common stock issued for working capital facility (in Shares)	100,000
Shares issued in lieu of interest	$ 11	250,996			251,007
Shares issued in lieu of interest (in Shares)	116,896
Warrants for services with the issuance of convertible debt		449,474			449,474
Cashless stock option exercise	$ 19	(19)
Cashless stock option exercise (in Shares)	185,111
Cashless warrant exercise
Cashless warrant exercise (in Shares)	1,377
Net loss			(11,873,555)		(11,873,555)
Foreign currency translation				(35,048)	(35,048)
Balances at Jun. 30, 2022	$ 2,478	135,322,838	(127,773,494)	176,438	7,728,260
Balances (in Shares) at Jun. 30, 2022	24,789,418
Balances at Mar. 31, 2022	$ 2,467	132,439,724	(121,200,667)	244,226	11,485,750
Balances (in Shares) at Mar. 31, 2022	24,672,522
Stock-based compensation		2,632,118			2,632,118
Shares issued in lieu of interest	$ 11	250,996			251,007
Shares issued in lieu of interest (in Shares)	116,896
Net loss			(6,572,827)		(6,572,827)
Foreign currency translation				(67,788)	(67,788)
Balances at Jun. 30, 2022	$ 2,478	$ 135,322,838	$ (127,773,494)	$ 176,438	$ 7,728,260
Balances (in Shares) at Jun. 30, 2022	24,789,418